Publications

This impact brief focuses on successful quality improvement interventions from the Maternal and Infant-Focused Neonatal Abstinence Syndrome (NAS) Investment Program for families impacted by opioid use disorder, including increasing non-pharmacologic interventions, optimizing pharmacologic treatment and hospital utilization, and improving access to wraparound treatments.

Poster presented at the AcademyHealth National Health Policy Conference in 2020, sharing findings on caring for infants with neonatal abstinence syndrome in a hospital setting in Massachusetts

In this annual report for 2019, the HPC presents new research to enhance the collective understanding of health care spending trends and cost drivers and evaluates progress in meeting the Commonwealth’s cost containment, care delivery, and payment system goals.

Emerging innovations and promising outcomes from an HPC investment program

This 2019 chartpack is one in a series of regularly reported updates on the impact of opioid use on acute care hospital utilization in the Commonwealth.

These profiles provide a high-level snapshot of Maternal and Infant-Focused Neonatal Abstinence Syndrome (NAS) Investment Program awardees, the care models they implemented, and the goals of their initiatives.

Poster presented at the AcademyHealth Annual Research Meeting in 2018, sharing strategies to coordinate care for pregnant and postpartum women with opioid use disorder in a hospital setting

Podium presentation shared at the AcademyHealth Annual Research Meeting in 2018, providing guidance to hospitalists and researchers on addressing and eliminating the stigma associated with substance use disorder.

This one-pager summarizes the HCII Neonatal Abstinence Syndrome (NAS) Investment Program.

This document summarizes the three pathways of the Health Care Innovation Investment (HCII) Program.